Personalized Nutrition And Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Ingredient (Proteins & Amino Acid, Vitamins, Minerals, Probiotics, Herbal/Botanic), By Dosage Form (Tablets/Capsules, Liquids, Powders, Other), By End Use (Supermarkets/Hypermarkets, Specialty Stores, Retail Pharmacies, Online Pharmacies & E-Commerce Sites), By Region, & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 54.72 Billion
CAGR (2026-2031)	13.82%
Fastest Growing Segment	Liquids
Largest Market	North America
Market Size (2031)	USD 118.98 Billion

Market Overview

The Global Personalized Nutrition And Supplements Market will grow from USD 54.72 Billion in 2025 to USD 118.98 Billion by 2031 at a 13.82% CAGR. Personalized nutrition and supplements involve tailored dietary recommendations and formulated products designed to meet an individual's unique biological and lifestyle needs, often determined through genetic, microbiome, or biomarker testing. The primary drivers fueling this market include the escalating global prevalence of chronic lifestyle-related diseases and a fundamental shift toward preventive healthcare. Additionally, rapid advancements in diagnostic technologies are enabling precise assessment of nutrient requirements, thereby supporting the sector's expansion beyond generic mass-market solutions.

Despite this growth, the market faces a significant challenge in the form of regulatory complexity, particularly concerning data privacy and the scientific validation of testing methods across different jurisdictions. However, consumer sentiment toward the broader category remains highly favorable, suggesting strong underlying demand. According to the Consumer Healthcare Products Association, in 2025, 92% of voters agreed that dietary supplements have had a positive impact on their overall health, wellness, and quality of life.

Key Market Drivers

The integration of Artificial Intelligence and big data in nutritional diagnostics is fundamentally reshaping the market by enabling the processing of complex biological datasets to drive precision health. Unlike traditional methods, AI algorithms now analyze vast arrays of microbiome, genetic, and metabolic data to generate highly specific dietary interventions, moving the industry from generalized advice to biologically targeted solutions. This technological capability is attracting significant investment as companies seek to scale their diagnostic infrastructure and improve the accuracy of their recommendations. For instance, according to Viome Life Sciences, September 2024, in a company press release, the organization secured $25 million in Series D funding specifically to launch its diagnostic division and expand its AI-driven preventative health technologies. This capital influx underscores the critical role of advanced data analytics in operationalizing personalized nutrition for the mass market.

Concurrently, the proliferation of wearable health technology and self-monitoring devices acts as a vital data acquisition engine, providing the continuous, real-time physiological feedback necessary for dynamic personalization. These devices track metrics such as heart rate variability, sleep quality, and activity levels, creating a feedback loop that allows nutrition providers to adjust recommendations based on an individual’s daily performance and recovery status. The commercial impact of this trend is evident in the financial results of major hardware manufacturers who facilitate this data collection. According to Garmin Ltd., February 2025, in the 'Annual Report 2024', the fitness segment revenue grew 31% year-over-year to $1.77 billion, driven largely by robust demand for advanced wearables. This surge in hardware adoption directly correlates with consumer expectations for tailored health solutions. According to the Council for Responsible Nutrition, October 2024, in the '2024 Consumer Survey', 69% of supplement users emphasize the importance of a personalized regimen when selecting their products, validating the strong link between technological engagement and customized care.

Download Free Sample Report

Key Market Challenges

Regulatory complexity serves as a significant impediment to the expansion of the global personalized nutrition and supplements market. As companies utilize sensitive biological data to formulate tailored products, they must navigate a fragmented legal landscape characterized by divergent data privacy mandates and inconsistent standards for scientific validation across jurisdictions. This lack of harmonization compels organizations to dedicate substantial resources to compliance, thereby increasing operational costs and delaying the deployment of innovative diagnostic tools in international markets.

Furthermore, the absence of a unified framework for verifying testing methods creates ambiguity that erodes consumer confidence. Without clear regulatory benchmarks, potential users often struggle to distinguish between scientifically validated personalized solutions and generic offerings, leading to hesitation in adoption. This confusion regarding the industry's oversight is quantifiable and detrimental to market penetration. According to the Consumer Healthcare Products Association, in 2025, 52% of voters held the misconception that the dietary supplement category was either unregulated or were unsure of its regulatory status. Such data illustrates how an opaque and complex regulatory environment fosters distrust, directly hampering the industry's ability to convert interest into sustained market growth.

Key Market Trends

The adoption of 3D-printing technology for customized dosage forms is revolutionizing nutrient delivery by overcoming traditional manufacturing limitations. This innovation allows for "polypills" where multiple ingredients are encapsulated in distinct layers, optimizing bioavailability and adherence. Unlike mass-produced supplements, 3D printing enables real-time dosage adjustments based on biological data, facilitating a dynamic supply chain. The sector's rapid expansion is illustrated by the performance of specialized manufacturers. According to FemTech World, January 2025, in the article '3D-printing nutrition firm Rem3dy Health named in inaugural Sunday Times 100 Tech list', Rem3dy Health reported that its revenues increased by an average of 100.04% per annum over three years, underscoring the transition toward tailored manufacturing.

Simultaneously, the rise of Femtech-driven personalized hormonal nutrition is addressing metabolic fluctuations associated with fertility and menopause. This trend moves beyond generic multivitamins toward phasic supplementation protocols that align nutrient intake with hormonal shifts. This targeted approach is attracting substantial capital as investors recognize the demand for biologically specific solutions. According to Jones Day, September 2025, in the article 'The Future is FemTech: Innovation and Investment in Women's Health', the FemTech market experienced a 55% year-over-year increase in 2024, driven by innovations prioritizing women's physiological requirements. This investment velocity indicates a maturing ecosystem where personalized nutrition is central to managing hormonal health.

Segmental Insights

The Liquids segment is emerging as the fastest-growing category within the global personalized nutrition and supplements market, driven by its superior bioavailability and dosing flexibility. Liquid formulations enable highly precise nutrient measurements, allowing for the creation of tailored regimens that align with specific biological needs more effectively than fixed solid dosages. Furthermore, the aging global population creates a robust demand for these easy-to-swallow alternatives, addressing significant compliance challenges associated with pill fatigue and dysphagia. This convergence of functional efficacy and demographic preference is fueling the segment’s accelerated market expansion.

Regional Insights

North America maintains a leading position in the global personalized nutrition and supplements market due to heightened consumer awareness regarding preventive healthcare and chronic disease management. The region benefits from the widespread adoption of digital health technologies, including genetic testing and data integration, which facilitate precise customization. Additionally, the presence of major industry players and a structured regulatory environment monitored by the U.S. Food and Drug Administration enhances product safety and consumer trust. These factors collectively drive the sustained expansion of the personalized nutrition sector throughout the region.

Recent Developments

• In December 2024, Bayer Consumer Health launched the Age Factor ecosystem, a holistic offering within its Precision Health business unit focused on healthy aging. The new system combined a specialized nutritional supplement, formulated to support cellular defense and resilience, with a biological age test developed in collaboration with a specialized diagnostic partner. The ecosystem also included a companion digital application to help consumers track their progress and optimize lifestyle choices based on personalized data. This launch represented a major strategic move by the company to address the growing consumer interest in longevity and science-backed personalized health interventions.
• In November 2024, Persona Nutrition introduced a white-label service enabling external brands to enter the personalized nutrition subscription market. This new business-to-business offering provided partners with a turnkey solution, including access to the company's proprietary nutritional assessment algorithm, drug-nutrient interaction checker, and manufacturing capabilities. The service was designed to allow companies to scale their wellness offerings efficiently without the need for extensive infrastructure investment. The initiative reflected the growing demand for customized health solutions and the company's strategy to leverage its operational expertise to support broader market adoption.
• In September 2024, Viome Life Sciences secured $25 million in a Series D funding round to establish a new diagnostics division. The company announced that this capital would support the expansion of its testing capabilities beyond oral and throat cancer detection to include other chronic diseases and aging-related conditions. The strategic initiative aimed to leverage the company's proprietary RNA sequencing technology and artificial intelligence platform to provide earlier detection and personalized health insights. This development underscored the company's commitment to shifting healthcare from reactive treatment to preventative personalized solutions.
• In July 2024, Zoe launched a new whole-food supplement product named Daily 30+, designed to enhance gut health and microbiome diversity. The product, formulated with over thirty distinct plant-based ingredients including nuts, seeds, and herbs, was introduced to help consumers easily meet dietary diversity goals. This launch followed the company's extensive research and randomized controlled trials demonstrating the positive impact of plant variety on metabolic outcomes. The supplement was developed to be sprinkled on meals, offering a convenient method to integrate complex nutrition into daily routines, marking a significant product expansion beyond the company's digital app-based guidance.

Key Market Players

• Amway Corporation
• Superior Supplements Inc
• Metagenics, Inc.
• Nutralliance, Inc.
• Archer Daniels Midland Company
• Viome Life Sciences, Inc.
• DNAFit Life Sciences Ltd
• Abbott Laboratories Inc
• Herbalife International of America, Inc.
• GX Sciences, LLC

By Ingredient	By Dosage Form	By End Use	By Region
Proteins & Amino Acid Vitamins Minerals Probiotics Herbal/Botanic	Tablets/Capsules Liquids Powders Other	Supermarkets/Hypermarkets Specialty Stores Retail Pharmacies Online Pharmacies & E-Commerce Sites	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Personalized Nutrition And Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Personalized Nutrition And Supplements Market, By Ingredient:

• Proteins & Amino Acid
• Vitamins
• Minerals
• Probiotics
• Herbal/Botanic

• Personalized Nutrition And Supplements Market, By Dosage Form:

• Tablets/Capsules
• Liquids
• Powders
• Other

• Personalized Nutrition And Supplements Market, By End Use:

• Supermarkets/Hypermarkets
• Specialty Stores
• Retail Pharmacies
• Online Pharmacies & E-Commerce Sites

• Personalized Nutrition And Supplements Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE